During the past decade and a half, studies of genetic predisposition, parathyroid tumorigenesis, and molecular genetics of familial hyperparathyroid disorders have started to unveil the molecular basis of pHPT. Primary HPT is found in several distinct disorders with autosomal dominant inheritance such as in multiple endocrine neoplasia type 1 (MEN1), MEN2A, the HPT-jaw tumor syndrome (HPT-JT), familial isolated hyperparathyroidism (FIHPT), autosomal dominant mild hyperparathyroidism (ADMH), and neonatal severe HPT (NSHPT).
Alpha-Klotho as a regulator of calcium homeostasis. Science 2007;316:1615-18.
Augmented Wnt signaling in a mammalian model of accelerated aging. Science 2007;317:803-06.
Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 2006;444:770-74.
Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells. J Endocrinol 2007;195:125-31.
Type I membrane klotho expression is decreased and inversely correlated to serum calcium in primary hyperparathyroidism. J Clin Endocrinol Metab 2008;93:4152-57.
Independent genetic events associated with the development of multiple parathyroid tumors in patients with primary hyperparathyroidism. Am J Pathol 2002;161:1299-306.
Parafibromin and APC as screening markers for malignant potential in atypical parathyroid adenomas. Endocr Pathol 2010.
Allelic loss of the retinoblastoma tumor suppressor gene: A marker for aggressive parathyroid tumors? J Clin Endocr Metab 1996;81:3194-96.
Loss of heterozygosity studies at the retinoblastoma and breast cancer susceptibility (BRCA2) loci in pituitary, parathyroid, pancreatic and carcinoid tumors. Clin Endo 1996;45:195-200.
Somatic and germline mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med 2003;349:1722-29.
Gene expression of parathyroid tumors: Molecular subclassification and identification of the potential malignant phenotype. Cancer Res 2004;64:7405-11.
Multiple endocrine neoplasia type 1: Clinical features and screening. Endocrinol Metab Clin N Am 1994;23:1-18.
Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 1997;276:404-07.
Menin, the product of the MEN1 gene, is a nuclear protein. Proc Natl Acad Sci USA 1998;95:1630-34.
Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription. Cell 1999;96:143-52.
Cell cycle regulation of menin expression. Cancer Res 1999;59:5097-101.
The tumor suppressor protein menin interacts with NF-kappaB proteins and inhibits NF-kappaB-mediated transactivation. Oncogene 2001;20:4917-25.
Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type beta signaling. Proc Natl Acad Sci USA 2001;98:3837-42.
Interaction of MLL amino terminal sequences with menin is required for transformation. Cancer Res 2007;67:7275-83.
The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis. Cell 2005;123:207-18.
Mechanisms of disease: Multiple endocrine neoplasia type 1-relation to chromatin modifications and transcription regulation. Nat Clin Pract Endocrinol Metab 2006;2:562-70.
Genetic basis of endocrine disease: Multiple endocrine neoplasia type 2. J Clin Endocrinol Metab 1995;80:1989-95.
GDNF signalling through the Ret receptor tyrosine kinase. Nature 1996;27:789-93.
Hereditary hyperparathyroidism- jaw tumor syndrome: The endocrine tumor gene HRPT2 maps to chromosome 1q21-q31. Am J Hum Genet 1995;56:944-50.
HRPT2, encoding parafibromin, is mutated in hyperparathyroidism- jaw tumor syndrome. Nat Genet 2002;32:676-80.
Parafibromin, a component of the human PAF complex, regulates growth factors and is required for embryonic development and survival in adult mice. Mol Cell Biol 2008;28:2930-40.
The parafibromin tumor suppressor protein inhibits cell proliferation by repression of the c-myc proto-oncogene. Proc Natl Acad Sci USA 2008;105:17420-25.
Familial hyperparathyroidism without multiple endocrine neoplasia. World J Surg 1997;1:22-28.
A family with isolated hyperparathyroidism segregating a missense MEN1 mutation and showing loss of the wild-type alleles in the parathyroid tumors. Am J Hum Genet 1998;63:1544-49.
Familial isolated hyperparathyroidism as a variant of multiple endocrine neoplasia type 1 in a large Danish pedigree. J Clin Endocrinol Metab 2000;85:165-67.
The calcium-sensing receptor: A window into the physiology and pathophysiology of mineral ion metabolism. Endocrine Rev 1996;17:289-307.
Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 1993;75:1297-303.
Mutations in the calcium-sensing receptor and their clinical implications. Horm Res 1997;48:199-208.
Neonatal severe hyperparathyroidism, secondary hyperparathyroidism, and familial hypocalciuric hypercalcemia: Multiple different phenotypes associated with an inactivating Alu insertion mutation of the calcium-sensing receptor gene. Am J Med Genet 1997;71:202-10.
Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cytoplasmic tail of the calcium receptor. J Clin Endocrinol Metab 2000;85:2042-47.
Calcium-sensing receptor (CASR) mutations in hypercalcemic states: Studies from a single endocrine clinic over three years. J Clin Endocrinol Metab 2010;95:1819-29.
A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Nat Genet 1995;11:389-94.